EN DE
Watch British American Tobacco PLC for free: we tell you when fair value or trend changes.
Data-driven stock valuation

British American Tobacco PLC (BATS) fair value: what the stock is really worth

As of Nov 2, 2026: fair value (intrinsic value) of British American Tobacco PLC stock £49.86, price £45.74, upside +9.0%, quality 69 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive GB · ISIN GB0002875804

BA British American Tobacco PLC logo Broad data Nov 1, 2026

British American Tobacco PLC

BATS · LSE
Fairly valued, in an uptrend

The stock costs about what our calculation considers fair.

Quality 69/100
Highly profitable · 25.0% net margin (TTM)
Generates free cash flow
Wide moat 79/100
Broad data
Fair value £49.86 · Fairly valued (+9.0%)
Moderate debt
5.8% dividend yield · Watch coverage
Mixed vs. peers (7/14)
Weak Growth (revenue 5y −0.1 %/yr in GBP)
Insider activity 25/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

£48.23 £17.31 Fair Value £49.86 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 1, 2026.

How to read this chart

60‑month range £17.31 – £48.23 · fair‑value band £27.68 – £75.63 · the £45.74 price screens below the £49.86 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 1, 2026.

Follow British American Tobacco in your weekly email

Every Wednesday you see whether British American Tobacco is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the United States, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa.

Show moreShow less

The company offers vapour products; heated products, which consists of a battery-powered device and a plant-based substance consumable that is heated; modern oral products, such as nicotine pouches; combustibles, including cigarette sticks and other tobacco stick products; traditional oral products, such as snus and moist snuff; and fine cut/roll-your-own tobacco products.

It sells its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel Snus brands, as well as Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, and State Express 555 brands.

The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is headquartered in London, the United Kingdom.

Stock analysis

British American Tobacco PLC (BATS) currently trades at £45.74, while our model-based Fair Value estimate is £49.86, so the stock looks roughly fairly valued today (gap 8.3%).

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of £59.72 per share, and 7 of the 23 models we run sit above the £45.74 price.

Bear case: the Growth DCF group reads lowest at £12.36, and 16 of the 23 models stay below the price. Data coverage for this calculation is high.

Scenario range: £27.68 (bear) to £75.63 (bull), the price of £45.74 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 69/100 (solid quality), in the Consumer Defensive sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

British American Tobacco PLC reported revenue of £25.6B in FY2025 versus £25.7B in FY2021, a compound −0.1%/yr. Reported net income was £7.8B in FY2025, compounding +3.4%/yr from FY2021.

Key figures

Market cap £99.5B Large · P/E ratio 15.6 · P/S ratio 3.86 · EPS (TTM) £2.93 · Dividend yield 5.8% · Net margin 25.0% · Return on equity 13.4% · Return on assets (EBIT) 2.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 79 out of 100 (medium confidence).

What moves the price

The share trades about 5% below its 52-week high and 21% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at 9%, BATS screens richer than that median.

Fair Value models

Bear £27.68 Fair Value £49.86 Bull £75.63
Price £45.74 · Upside +9.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF £17.17 £30.33 £49.56 78
Growth DCF £18.27 £30.80 £48.46 77
Owner Earnings £23.33 £39.21 £62.40 75
All 23 models by family
DCF Models
FCF DCF £17.17 £30.33 £49.56 78
Owner Earnings £23.33 £39.21 £62.40 75
5Y Revenue Exit £5.37 £11.85 £19.52 70
5Y EBITDA Exit £29.11 £53.42 £80.30 74
5Y P/E Exit £29.81 £54.65 £79.05 70
10Y Revenue Exit £9.06 £15.63 £23.19 66
10Y EBITDA Exit £24.47 £44.07 £67.77 67
10Y P/E Exit £24.91 £44.91 £66.85 63
Earnings-Based
Graham-Dodd £24.55 £51.89 £65.77 66
PEG = 1.0 £7.83 £11.19 £14.55 57
EPV £23.75 £30.16 £35.84 74
Dividend Discount
Gordon GGM £23.30 £36.09 £50.40 68
DDM Multi-Stage £23.30 £33.89 £46.42 66
Multiples
P/E Multiple £56.86 £75.82 £94.77 63
P/S Multiple £14.29 £19.05 £23.82 58
EV/EBIT £44.43 £64.18 £83.94 65
EV/EBITDA £40.77 £59.31 £77.85 67
EV/Revenue n/a £3.02 £8.38 50
Growth DCF
Growth DCF £18.27 £30.80 £48.46 77
Rev-Margin DCF £5.37 £12.36 £19.84 70
Economic Profit
Residual Income £24.14 £29.62 £41.70 75
ROIC Compounder £23.95 £32.29 £41.83 72
Growth Earnings
Growth-Adj P/E £41.81 £59.72 £77.64 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 69/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 51
How much profit the company makes from its sales and capital
Quality Growth 65
Are margins and returns getting better?
Cashflow 60
Do the profits arrive as real cash?
Financial strength 41
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 89
How calm the share price moves, does not count
Price momentum 48
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 66
Distance to the 52-week high, does not count
New shares 91
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−1.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.1%
Start year 2020 (pandemic). Over 10 years: +6.9% a year
Revenue growth 30 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.5%
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+8.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+3.1%
Dividend (yield on the price)5.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.4.6% vs 6.4%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.39% → 39%
2025 sits 63% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+13.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+3.1%
Yearly sales growth analysts expect, extended to five years.
After inflation (UK: IMF forecast 2.3% a year to 2030, 3.3% from 2016 to 2025) that is about +11.1% a year for the price and +0.7% for the forecasts.
Forecast 2026 (sales)+2.1%
Forecast 2027 (sales)+3.6%
Projected 2028 (sales)+3.4%
Projected 2029 (sales)+3.2%
Projected 2030 (sales)+3.0%

Watch BATS, get fair value alerts →

Earlier news

News mood ⓘNews mood, the average tone of recent news (96 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Neutral
Recent news coverage is roughly neutral, about typical for how stocks are covered.

Compare British American Tobacco PLC with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Tobacco · 29 stocks

Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 69 · Above median
Fair Value upside +9.0% · Above median
Profitability
Return on equity (12 months) 13.4% · Below median
Return on assets 7.1% · Below median
Net margin (12 months) 25.0% · Top 25%
Operating margin (12 months) 34.9% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 1.4% · Below median
Dividend yield (12 months) 5.8% · Above median
Balance sheet
Debt / equity 0.65× · Highest 25%

Valuation Multiplesvs Tobacco median · lower = cheaper

P/E (12 months) 15.6× · Cheaper than median
P/B 2.08× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 3.86× · Priciest 25%
Price / free cash flow 22.8× · Pricier than median
EV/EBITDA 11.3× · Cheaper than median
PEG 1.40× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)45 · sector 40
FUTURE (revenue growth)7 · sector 25
PAST (return on equity)54 · sector 55
HEALTH (low debt)67 · sector 96
DIVIDEND (yield)100 · sector 82

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Tobacco

Similar stocks

10 more Tobacco stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
RLX Technology Inc RLX $1.61 $2.78 +73% vs BATS
TABAK TABAK 17,380 CZK 23,215 CZK +34% vs BATS
PT Gudang Garam Tbk, GGRM 16,100 IDR 20,535 IDR +28% vs BATS
China Tobacco International (HK) Company 6055 HK$24.52 HK$30.63 +25% vs BATS
ITC Limited ITC ₹266.40 ₹292.16 +10% vs BATS
Altria Group MO $78.03 $82.13 +5% vs BATS
PT Hanjaya Mandala Sampoerna Tbk, HMSP 650.00 IDR 570.44 IDR −12% vs BATS
Godfrey Phillips India Limited GODFRYPHLP ₹1,700 ₹1,050 −38% vs BATS
KT&G Corporation 033780 192,600 KRW 104,858 KRW −46% vs BATS
Philip Morris International Inc PM $208.79 $112.99 −46% vs BATS

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

British American Tobacco PLC: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "British American Tobacco PLC Fair Value". https://www.fairvalue-calculator.com/stock/BATS

Frequently asked questions

Is British American Tobacco PLC (BATS) overvalued or undervalued?
As of Nov 1, 2026, our model estimates a fair value of £49.86 versus a price of £45.74, about +9% upside (fairly valued).
What is the fair value of BATS?
Our model-based fair value for British American Tobacco PLC is £49.86 (as of Nov 1, 2026), built from audited fundamentals. The current price: £45.74.
What is the quality score of BATS?
British American Tobacco PLC has a Quality Score of 69/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for British American Tobacco PLC (BATS)?
Our model-based price target is the fair value of £49.86 (as of Nov 1, 2026) from 23 valuation models. Cautious scenario £27.68, optimistic scenario £75.63. It is a calculation from audited fundamentals, not an analyst target.
What is the British American Tobacco PLC stock forecast for 2026?
Our models put fair value at £49.86, about +9% upside versus a price of £45.74 (fairly valued). Cautious scenario £27.68, optimistic scenario £75.63. The calculation is refreshed regularly with new filings.
What is the revenue of British American Tobacco PLC (BATS)?
British American Tobacco PLC reported trailing-twelve-month revenue of about £25.8B (latest available figure, as of Nov 1, 2026).
Does British American Tobacco PLC pay a dividend?
British American Tobacco PLC currently shows a dividend yield of 5.75% relative to its recent price (as of Nov 1, 2026).
What growth is priced into British American Tobacco PLC (BATS)?
For today's price to be fair in a discounted-cash-flow model, British American Tobacco PLC would have to grow free cash flow by +13.7 % per year for five years (discount rate 8.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -0.1 % per year. As of Nov 1, 2026.
What discount rate (WACC) does the fair value of BATS use?
Our models discount British American Tobacco PLC at 8.6 %: a base by market capitalisation (large), damped by beta 0.10, country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For British American Tobacco PLC that is +13.7 % per year a year over ten years, using the same discount rate (8.6 %) and the same formula as our fair value.
How much growth has British American Tobacco PLC (BATS) delivered so far?
Over the past 5 years revenue at British American Tobacco PLC grew -0.1 % a year. The price currently implies +13.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of British American Tobacco PLC (BATS) growing?
The median revenue growth in the sector is +3.4 % a year. That is the yardstick for the growth priced into British American Tobacco PLC (+13.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of British American Tobacco PLC (BATS)?
The free-cash-flow yield on the price is 4.38 %: that much free cash flow British American Tobacco PLC produces per unit of market value. When it exceeds the discount rate of our models (8.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of British American Tobacco PLC (BATS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For British American Tobacco PLC it is £49.86 per share (as of Nov 1, 2026), against a price of £45.74. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is British American Tobacco PLC stock overvalued or undervalued in 2026?
As of Nov 1, 2026, BATS trades below its calculated fair value: price £45.74, fair value £49.86, a gap of about +9% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BATS?
No. The price is what the market pays today (£45.74); the fair value is what the company's own numbers justify (£49.86). For British American Tobacco PLC the two are £4.12 per share apart. That gap is exactly why we show both numbers side by side.
How much is British American Tobacco PLC worth?
The market values British American Tobacco PLC at about £99.5B (market capitalisation, as of Nov 1, 2026). Per share that is £45.74; our models calculate a fair value of £49.86 per share.
What do the bullish and bearish scenarios say about BATS?
Our models span a range for British American Tobacco PLC: cautious scenario £27.68, base £49.86, optimistic £75.63 per share (as of Nov 1, 2026, price £45.74). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BATS?
British American Tobacco PLC trades at a price-to-earnings ratio of 15.6 (as of Nov 1, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of £49.86 is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2016 to 2025), reported earnings, 6 of the years ex one-offs: 10.8. Other multiples: PEG 1.4, P/B 2.1, P/S 3.9, EV/EBITDA 11.3.
What is the PEG ratio of BATS?
The PEG ratio of British American Tobacco PLC is 1.40 (P/E divided by earnings growth, as of Nov 1, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of British American Tobacco PLC (BATS)?
Balance-sheet figures for British American Tobacco PLC (as of Nov 1, 2026): return on equity 13.4%, debt of 0.65 per unit of equity. They feed the Quality Score of 69/100, which measures business quality independently of the share price.
How far is BATS from its 52-week high?
British American Tobacco PLC trades at £45.74, about 5% below its 52-week high of £48.23 and 21% above the low of £37.87 (as of Nov 2, 2026). Distance from the high says nothing about value: that is what the fair value of £49.86 is for.
Which stocks are comparable to British American Tobacco PLC?
From the same area (Consumer Defensive) we also value Philip Morris International Inc, Altria Group, ITC Limited, KT&G Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is British American Tobacco PLC stock attractive at the current price?
The data as of Nov 1, 2026: price £45.74, calculated fair value £49.86 (+9%), Quality Score 69/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BATS calculated?
We run British American Tobacco PLC through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of £49.86, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.2 % above its aggregate fair value. British American Tobacco PLC currently trades 8 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of British American Tobacco PLC (BATS)?
The closing price on Nov 2, 2026 was £45.74. Our model-based fair value is £49.86, about +9% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with British American Tobacco PLC right now?
The model range is unusually wide (£27.68 to £75.63). The outcome hinges heavily on assumptions, so read the point estimate with caution. The price sits close to our fair value, market and models broadly agree here, little valuation tension.
Where does the earnings growth of British American Tobacco PLC (BATS) come from?
Earnings per share at British American Tobacco PLC grew +3.4 % a year from 2014 to 2025. Broken into its drivers: revenue per share +7.1 %, EBIT margin −3.1 %, tax rate +1.0 %, residual (interest, one-offs) −1.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of British American Tobacco PLC

How large is the market capitalisation of British American Tobacco PLC (BATS)?
The market capitalisation of British American Tobacco PLC is £99.5B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of British American Tobacco PLC (BATS)?
The price-to-sales ratio of British American Tobacco PLC is 3.86 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of British American Tobacco PLC (BATS)?
Earnings per share at British American Tobacco PLC are £2.93 (price ÷ EPS = P/E 15.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of British American Tobacco PLC (BATS)?
The dividend yield of British American Tobacco PLC is 5.8% (payout 89.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of British American Tobacco PLC (BATS)?
The net margin of British American Tobacco PLC is 25.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of British American Tobacco PLC (BATS)?
The return on equity (ROE) of British American Tobacco PLC is 13.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of British American Tobacco PLC (BATS)?
On an EBIT basis the return on assets of British American Tobacco PLC is 2.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of British American Tobacco PLC (BATS)?
The operating margin of British American Tobacco PLC is 34.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at British American Tobacco PLC (BATS)?
Revenue at British American Tobacco PLC is growing +1.4% versus a year earlier (3y avg −2.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at British American Tobacco PLC (BATS)?
Earnings per share at British American Tobacco PLC are growing −28.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does British American Tobacco PLC (BATS) carry?
The net debt of British American Tobacco PLC is £31.9B (fiscal year 2025, ≈ 7.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch British American Tobacco PLC in the live analysis

One click puts British American Tobacco PLC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.